Page last updated: 2024-11-05

2-chlorobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Chlorobenzoic acid, also known as o-chlorobenzoic acid, is a white crystalline solid with a melting point of 140-142 °C. It is a common industrial chemical used as an intermediate in the production of other chemicals, such as dyes, pharmaceuticals, and pesticides. It can be synthesized through various methods, including the chlorination of benzoic acid or the oxidation of 2-chlorotoluene. 2-Chlorobenzoic acid is a weak acid with a pKa of 2.9. It is also a known irritant and can cause skin and eye irritation upon contact. The compound is studied for its potential applications in organic synthesis, and its environmental impact is also investigated. 2-Chlorobenzoic acid can be found in various environmental matrices, including soil, water, and air.'

2-chlorobenzoic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chlorobenzoic acid : Any member of the class of benzoic acids in which the benzene ring is substituted by at least one chloro group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-chlorobenzoic acid : A monochlorobenzoic acid having the chloro group at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8374
CHEMBL ID115243
CHEBI ID30793
SCHEMBL ID367
MeSH IDM0167881

Synonyms (71)

Synonym
CHEBI:30793 ,
nsc-32737
nsc32737
AB-131/40168737
inchi=1/c7h5clo2/c8-6-4-2-1-3-5(6)7(9)10/h1-4h,(h,9,10
nsc-15042
nsc15042
wln: qvr bg
benzoic acid, o-chloro-
benzoic acid, 2-chloro-
kyselina o-chlorbenzoova
2-cba
NCGC00090894-01
nsc 15042
brn 0907340
ai3-03714
ccris 5993
hsdb 6017
einecs 204-285-4
kyselina o-chlorbenzoova [czech]
STK301675
2-chlorobenzoic acid
C02357
118-91-2
o-chlorobenzoic acid
2-chlorobenzoic acid, analytical standard
2-chlorobenzoic acid, 98%
NCIOPEN2_004799
BMSE000332
2-chloro-benzoic acid
CHEMBL115243
AKOS000119016
A804125
NCGC00090894-02
unii-8p0867193v
8p0867193v ,
dtxsid4024771 ,
tox21_200286
cas-118-91-2
dtxcid304771
NCGC00257840-01
chlorobenzoic acid
benzoic acid, chloro-
26264-09-5
FT-0611913
SCHEMBL367
o-chlorobenzoic acid [mi]
rwj-333369 metabolite m4
tolfenamic acid impurity a [ep impurity]
mesalazine impurity l [ep impurity]
r300100 ,
o-chlorobenzoic acid [hsdb]
chlorobenzoic acid, o-
mefenamic acid impurity c [ep impurity]
PS-5349
AM86361
Q-200261
CS-B1789
benzoic acid,chloro-
F9995-1661
mfcd00002412
2-chlorobenzoic acid, vetec(tm) reagent grade, 98%
mefenamic acid imp. c (ep); mesalazine imp. l (ep); 2-chlorobenzoic acid; mefenamic acid impurity c; mesalazine impurity l; tolfenamic acid impurity a
Z57127537
m02 2-chlorobenzoic acid
Q2823208
2-chlorobenzoic acid zone refined (number of passes:20)
D77315
EN300-18043
2-chlorobenzoic-d4 acid
2-chloro benzoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant hormoneA plant growth regulator that modulates the formation of stems, leaves and flowers, as well as the development and ripening of fruit. The term includes endogenous and non-endogenous compounds (e.g. active compounds produced by bacteria on the leaf surface) as well as semi-synthetic and fully synthetic compounds.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monochlorobenzoic acid
2-halobenzoic acidA benzoic acid in which an unspecified halogen atom is bonded to the carbon atom adjacent to the carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency27.25050.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency21.64580.000714.592883.7951AID1259392
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency7.94330.011212.4002100.0000AID1030
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.04360.000229.305416,493.5996AID743075
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency0.869419.739145.978464.9432AID1159509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1127992Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1145614Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1127995Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1145605Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145615Dissociation constant, pKa of the compound at pH 7.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1127996Toxicity in fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID28497log (1/C') was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID631927Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously measured after 24 hrs2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID1605095Inhibition of N-terminal His6-sumo-tagged full length Staphylococcus aureus ClpP expressed in Escherichia coli BL2 (DE3) at 10 uM pre-incubated for 10 mins before Suc-LY-AMC addition and measured after 1 hr by fluorescence based assay relative to control2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
AID28690Concentration required to kill 50% of the mosquito larva in 24 hr.1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID631930Dissociation constant, pKa of the compound2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID1145616Increase in membrane potential in mollusc neurons assessed as conductance of potassium at pH 7.8 relative to salicylic acid1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (12.50)18.7374
1990's10 (25.00)18.2507
2000's15 (37.50)29.6817
2010's9 (22.50)24.3611
2020's1 (2.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.45 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index83.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other41 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]